Profilo
Kelly Devine Deck is currently the Chief Financial Officer at Inhibrx, Inc. and a Trustee at The Fleet Science Center.
Previously, she worked as the Executive Director-Finance at Apricus Biosciences, Inc. from 2013 to 2018.
Posizioni attive di Kelly Deck
| Società | Posizione | Inizio |
|---|---|---|
| INHIBRX, INC. | Director of Finance/CFO | - |
| Fleet Science Center | Director/Board Member | - |
Precedenti posizioni note di Kelly Deck
| Società | Posizione | Fine |
|---|---|---|
Apricus Biosciences, Inc.
 Apricus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Apricus Biosciences, Inc. is a biopharmaceutical company, which engages in the development and commercialization of product candidates in the areas of specialty urology and rheumatology. Its products include Vitaros and Femprox. The company was founded in 1987 and is headquartered in San Diego, CA. | Director of Finance/CFO | 01/01/2018 |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| INHIBRX, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Apricus Biosciences, Inc.
Apricus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Apricus Biosciences, Inc. is a biopharmaceutical company, which engages in the development and commercialization of product candidates in the areas of specialty urology and rheumatology. Its products include Vitaros and Femprox. The company was founded in 1987 and is headquartered in San Diego, CA. | Health Technology |
| Fleet Science Center |
- Borsa valori
- Insiders
- Kelly Deck
